BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12186278)

  • 1. Varlirix (GlaxoSmithKline).
    Arvin AM
    Curr Opin Investig Drugs; 2002 Jul; 3(7):996-9. PubMed ID: 12186278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of the Varilrix varicella vaccine.
    Chiu SS; Lau YL
    Expert Rev Vaccines; 2005 Oct; 4(5):629-43. PubMed ID: 16221065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varivax (Merck & Co).
    Jones T
    Curr Opin Investig Drugs; 2002 Jan; 3(1):54-7. PubMed ID: 12054073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protective effect of vaccination against chickenpox].
    Plesník V; Príkazský V; Pĕtvaldská L
    Epidemiol Mikrobiol Imunol; 2000 Nov; 49(4):143-7. PubMed ID: 11188760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of resistance to acyclovir during chronic infection with the Oka vaccine strain of varicella-zoster virus, in an immunosuppressed child.
    Levin MJ; Dahl KM; Weinberg A; Giller R; Patel A; Krause PR
    J Infect Dis; 2003 Oct; 188(7):954-9. PubMed ID: 14513413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of shingles by varicella zoster virus vaccination.
    Holodniy M
    Expert Rev Vaccines; 2006 Aug; 5(4):431-43. PubMed ID: 16989624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotyping of different varicella vaccine strains.
    Sauerbrei A; Zell R; Harder M; Wutzler P
    J Clin Virol; 2006 Oct; 37(2):109-17. PubMed ID: 16905356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chickenpox vaccines: new drugs. A favourable risk-benefit balance in some situations.
    Prescrire Int; 2005 Jun; 14(77):85-91. PubMed ID: 15977369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varicella vaccine revisited.
    Seward J; Jumaan A; Schmid S
    Nat Med; 2000 Dec; 6(12):1298-300. PubMed ID: 11100088
    [No Abstract]   [Full Text] [Related]  

  • 10. Acyclovir-resistant chronic verrucous vaccine strain varicella in a patient with neuroblastoma.
    Bryan CJ; Prichard MN; Daily S; Jefferson G; Hartline C; Cassady KA; Hilliard L; Shimamura M
    Pediatr Infect Dis J; 2008 Oct; 27(10):946-8. PubMed ID: 18776818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic understanding and control of varicella-zoster virus infection.
    Asano Y
    Vaccine; 2008 Nov; 26(50):6487-90. PubMed ID: 18694794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells.
    Levy O; Orange JS; Hibberd P; Steinberg S; LaRussa P; Weinberg A; Wilson SB; Shaulov A; Fleisher G; Geha RS; Bonilla FA; Exley M
    J Infect Dis; 2003 Oct; 188(7):948-53. PubMed ID: 14513412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety profile of varicella vaccine: a 10-year review.
    Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
    J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of clinical varicella-zoster strains from India and differentiation from the oka vaccine strain.
    Kaushik KS; Lahiri KK; Chumber SK; Gupta RM; Kumar S; Kapila K; Karade S
    Jpn J Infect Dis; 2008 Jan; 61(1):65-7. PubMed ID: 18219137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX in healthy children.
    Lau YL; Vessey SJ; Chan IS; Lee TL; Huang LM; Lee CY; Lin TY; Lee BW; Kwan K; Kasim SM; Chan CY; Kaplan KM; Distefano DJ; Harmon AL; Golie A; Hartzel J; Xu J; Li S; Matthews H; Sadoff JC; Shaw A
    Vaccine; 2002 Jul; 20(23-24):2942-9. PubMed ID: 12126906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and quality control of the Oka-strain live varicella vaccine.
    D'Hondt E; Berge E; Colinet G; Duchene M; Peetermans J
    Postgrad Med J; 1985; 61 Suppl 4():53-6. PubMed ID: 3014478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varicella zoster vaccines.
    Creed R; Satyaprakash A; Ravanfar P
    Dermatol Ther; 2009; 22(2):143-9. PubMed ID: 19335725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine.
    Watson B
    J Infect Dis; 2008 Mar; 197 Suppl 2():S143-6. PubMed ID: 18419388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine-strain varicella zoster virus causing recurrent herpes zoster in an immunocompetent 2-year-old.
    Ota K; Kim V; Lavi S; Ford-Jones EL; Tipples G; Scolnik D; Tellier R
    Pediatr Infect Dis J; 2008 Sep; 27(9):847-8. PubMed ID: 18664930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspective on live varicella vaccine.
    Gershon AA; Katz SL
    J Infect Dis; 2008 Mar; 197 Suppl 2():S242-5. PubMed ID: 18419404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.